Annual Working Capital
-$2.82 M
-$12.89 M-128.02%
December 31, 2023
Summary
- As of March 1, 2025, EVOK annual working capital is -$2.82 million, with the most recent change of -$12.89 million (-128.02%) on December 31, 2023.
- During the last 3 years, EVOK annual working capital has fallen by -$4.57 million (-261.66%).
- EVOK annual working capital is now -112.74% below its all-time high of $22.15 million, reached on December 31, 2013.
Performance
EVOK Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.27 M
+$1.61 M+60.29%
September 30, 2024
Summary
- As of March 1, 2025, EVOK quarterly working capital is $4.27 million, with the most recent change of +$1.61 million (+60.29%) on September 30, 2024.
- Over the past year, EVOK quarterly working capital has increased by +$7.09 million (+251.41%).
- EVOK quarterly working capital is now -80.71% below its all-time high of $22.15 million, reached on December 31, 2013.
Performance
EVOK Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
EVOK Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -128.0% | +251.4% |
| 3 y3 years | -261.7% | -37.6% |
| 5 y5 years | -170.3% | -37.6% |
EVOK Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -128.0% | at low | -67.3% | +251.4% |
| 5 y | 5-year | -128.0% | at low | -67.3% | +251.4% |
| alltime | all time | -112.7% | at low | -80.7% | +251.4% |
Evoke Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.27 M(+60.3%) |
| Jun 2024 | - | $2.67 M(-23.8%) |
| Mar 2024 | - | $3.50 M(-224.0%) |
| Dec 2023 | -$2.82 M(-128.0%) | -$2.82 M(-150.4%) |
| Sep 2023 | - | $5.60 M(-18.2%) |
| Jun 2023 | - | $6.85 M(-17.2%) |
| Mar 2023 | - | $8.27 M(-17.9%) |
| Dec 2022 | $10.07 M(+10.0%) | $10.07 M(-11.5%) |
| Sep 2022 | - | $11.38 M(-12.8%) |
| Jun 2022 | - | $13.05 M(+70.2%) |
| Mar 2022 | - | $7.67 M(-16.2%) |
| Dec 2021 | $9.15 M(+424.6%) | $9.15 M(-10.3%) |
| Sep 2021 | - | $10.21 M(-9.2%) |
| Jun 2021 | - | $11.24 M(-13.0%) |
| Mar 2021 | - | $12.93 M(+640.8%) |
| Dec 2020 | $1.75 M(-58.7%) | $1.75 M(+1766.4%) |
| Sep 2020 | - | $93.50 K(-94.0%) |
| Jun 2020 | - | $1.56 M(-44.8%) |
| Mar 2020 | - | $2.82 M(-33.4%) |
| Dec 2019 | $4.23 M(+5.4%) | $4.23 M(-17.7%) |
| Sep 2019 | - | $5.14 M(-18.1%) |
| Jun 2019 | - | $6.28 M(+111.2%) |
| Mar 2019 | - | $2.97 M(-25.9%) |
| Dec 2018 | $4.01 M | $4.01 M(-25.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $5.40 M(+0.7%) |
| Jun 2018 | - | $5.36 M(+22.1%) |
| Mar 2018 | - | $4.39 M(-25.0%) |
| Dec 2017 | $5.86 M(-25.6%) | $5.86 M(-27.7%) |
| Sep 2017 | - | $8.10 M(-28.1%) |
| Jun 2017 | - | $11.27 M(-17.7%) |
| Mar 2017 | - | $13.69 M(+73.9%) |
| Dec 2016 | $7.87 M(+2.4%) | $7.87 M(-19.7%) |
| Sep 2016 | - | $9.80 M(-741.9%) |
| Jun 2016 | - | -$1.53 M(-134.4%) |
| Mar 2016 | - | $4.44 M(-42.3%) |
| Dec 2015 | $7.69 M(-42.5%) | $7.69 M(-20.5%) |
| Sep 2015 | - | $9.67 M(+30.4%) |
| Jun 2015 | - | $7.41 M(-26.4%) |
| Mar 2015 | - | $10.07 M(-24.7%) |
| Dec 2014 | $13.38 M(-39.6%) | $13.38 M(+15.1%) |
| Sep 2014 | - | $11.62 M(-23.0%) |
| Jun 2014 | - | $15.10 M(-20.8%) |
| Mar 2014 | - | $19.07 M(-13.9%) |
| Dec 2013 | $22.15 M(-4973.7%) | $22.15 M(+5.0%) |
| Sep 2013 | - | $21.10 M(>+9900.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | -$454.40 K(-179.6%) | -$454.40 K |
| Dec 2011 | $570.80 K | - |
FAQ
- What is Evoke Pharma annual working capital?
- What is the all time high annual working capital for Evoke Pharma?
- What is Evoke Pharma annual working capital year-on-year change?
- What is Evoke Pharma quarterly working capital?
- What is the all time high quarterly working capital for Evoke Pharma?
- What is Evoke Pharma quarterly working capital year-on-year change?
What is Evoke Pharma annual working capital?
The current annual working capital of EVOK is -$2.82 M
What is the all time high annual working capital for Evoke Pharma?
Evoke Pharma all-time high annual working capital is $22.15 M
What is Evoke Pharma annual working capital year-on-year change?
Over the past year, EVOK annual working capital has changed by -$12.89 M (-128.02%)
What is Evoke Pharma quarterly working capital?
The current quarterly working capital of EVOK is $4.27 M
What is the all time high quarterly working capital for Evoke Pharma?
Evoke Pharma all-time high quarterly working capital is $22.15 M
What is Evoke Pharma quarterly working capital year-on-year change?
Over the past year, EVOK quarterly working capital has changed by +$7.09 M (+251.41%)